tiprankstipranks
Sinopharm Group Co Ltd Class H (HK:1099)
:1099
Hong Kong Market
1099
Sinopharm Group Co
RESEARCH TOOLSreports

Sinopharm Group Co (1099) Stock Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

1099 Analyst Ratings

Strong Buy
7Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Sinopharm
Group Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1099 Stock 12 Month Forecast

Average Price Target

HK$23.32
▲(15.00% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Sinopharm Group Co in the last 3 months. The average price target is HK$23.32 with a high forecast of HK$26.70 and a low forecast of HK$19.83. The average price target represents a 15.00% change from the last price of HK$20.28.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"HK$16","27":"HK$27","18.75":"HK$18.75","21.5":"HK$21.5","24.25":"HK$24.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":26.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$26.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.322857142857146,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$23.32</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$19.83</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,18.75,21.5,24.25,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.12,21.54923076923077,21.978461538461538,22.407692307692308,22.836923076923078,23.26615384615385,23.695384615384615,24.124615384615385,24.553846153846152,24.983076923076922,25.412307692307692,25.841538461538462,26.27076923076923,{"y":26.7,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.12,21.28945054945055,21.4589010989011,21.62835164835165,21.7978021978022,21.96725274725275,22.1367032967033,22.306153846153848,22.475604395604396,22.645054945054948,22.814505494505497,22.983956043956045,23.153406593406597,{"y":23.322857142857146,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.12,21.020769230769233,20.92153846153846,20.822307692307692,20.723076923076924,20.623846153846152,20.524615384615384,20.425384615384615,20.326153846153847,20.226923076923075,20.127692307692307,20.02846153846154,19.929230769230767,{"y":19.83,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.855,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.759,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.759,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.826,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.595,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.634,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.884,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.38,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.84,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.75,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.12,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$26.70Average Price TargetHK$23.32Lowest Price TargetHK$19.83
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
First Shanghai Securities Analyst forecast on HK:1099
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
HK$26.7
Buy
31.66%
Upside
Reiterated
04/04/26
Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities
CICC Analyst forecast on HK:1099
Unknown Analyst
CICC
Not Ranked
CICC
HK$24.7
Buy
21.79%
Upside
Reiterated
03/27/26
Sinopharm Group Co (SHTDF) Receives a Buy from CICC
Huatai Securities Analyst forecast on HK:1099
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$22.53
Buy
11.09%
Upside
Reiterated
03/24/26
Huatai Securities Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Daiwa Analyst forecast on HK:1099
Unknown Analyst
Daiwa
Not Ranked
Daiwa
HK$21
Buy
3.55%
Upside
Reiterated
03/24/26
Daiwa Reaffirms Their Buy Rating on Sinopharm Group Co (SHTDF)
UBS Analyst forecast on HK:1099
Unknown Analyst
UBS
Not Ranked
UBS
HK$25.7
Buy
26.73%
Upside
Reiterated
03/23/26
UBS Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Citi Analyst forecast on HK:1099
Unknown Analyst
Citi
Not Ranked
Citi
HK$22.8
Buy
12.43%
Upside
Reiterated
03/23/26
Citi Sticks to Their Buy Rating for Sinopharm Group Co (SHTDF)
Goldman Sachs Analyst forecast on HK:1099
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$19.83
Hold
-2.22%
Downside
Reiterated
03/23/26
Sinopharm Group Co (SHTDF) Gets a Hold from Goldman Sachs
HSBC Analyst forecast on HK:1099
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$18→HK$19.5
Sell
-3.85%
Downside
Reiterated
11/10/25
HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)
China Renaissance Analyst forecast on HK:1099
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$23.6
Buy
16.37%
Upside
Reiterated
08/26/25
UOB Kay Hian Analyst forecast on HK:1099
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$17.3
Sell
-14.69%
Downside
Reiterated
08/26/25
Bank of America Securities Analyst forecast on HK:1099
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$23
Buy
13.41%
Upside
Reiterated
08/25/25
Morgan Stanley Analyst forecast on HK:1099
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$22.5
Buy
10.95%
Upside
Reiterated
08/22/25
Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group
Citic Securities Analyst forecast on HK:1099
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$22
Buy
8.48%
Upside
Reiterated
06/16/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
First Shanghai Securities Analyst forecast on HK:1099
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
HK$26.7
Buy
31.66%
Upside
Reiterated
04/04/26
Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai Securities
CICC Analyst forecast on HK:1099
Unknown Analyst
CICC
Not Ranked
CICC
HK$24.7
Buy
21.79%
Upside
Reiterated
03/27/26
Sinopharm Group Co (SHTDF) Receives a Buy from CICC
Huatai Securities Analyst forecast on HK:1099
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
HK$22.53
Buy
11.09%
Upside
Reiterated
03/24/26
Huatai Securities Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Daiwa Analyst forecast on HK:1099
Unknown Analyst
Daiwa
Not Ranked
Daiwa
HK$21
Buy
3.55%
Upside
Reiterated
03/24/26
Daiwa Reaffirms Their Buy Rating on Sinopharm Group Co (SHTDF)
UBS Analyst forecast on HK:1099
Unknown Analyst
UBS
Not Ranked
UBS
HK$25.7
Buy
26.73%
Upside
Reiterated
03/23/26
UBS Keeps Their Buy Rating on Sinopharm Group Co (SHTDF)
Citi Analyst forecast on HK:1099
Unknown Analyst
Citi
Not Ranked
Citi
HK$22.8
Buy
12.43%
Upside
Reiterated
03/23/26
Citi Sticks to Their Buy Rating for Sinopharm Group Co (SHTDF)
Goldman Sachs Analyst forecast on HK:1099
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$19.83
Hold
-2.22%
Downside
Reiterated
03/23/26
Sinopharm Group Co (SHTDF) Gets a Hold from Goldman Sachs
HSBC Analyst forecast on HK:1099
Unknown Analyst
HSBC
Not Ranked
HSBC
HK$18→HK$19.5
Sell
-3.85%
Downside
Reiterated
11/10/25
HSBC Keeps Their Sell Rating on Sinopharm Group Co (SHTDF)
China Renaissance Analyst forecast on HK:1099
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$23.6
Buy
16.37%
Upside
Reiterated
08/26/25
UOB Kay Hian Analyst forecast on HK:1099
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$17.3
Sell
-14.69%
Downside
Reiterated
08/26/25
Bank of America Securities Analyst forecast on HK:1099
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$23
Buy
13.41%
Upside
Reiterated
08/25/25
Morgan Stanley Analyst forecast on HK:1099
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$22.5
Buy
10.95%
Upside
Reiterated
08/22/25
Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group
Citic Securities Analyst forecast on HK:1099
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
HK$22
Buy
8.48%
Upside
Reiterated
06/16/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

3 Months
xxx
Success Rate
4/4 ratings generated profit
100%
Average Return
+10.95%
reiterated a xxx
 rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.95% per trade.
1 Year
Laurence TamMorgan Stanley
Success Rate
3/4 ratings generated profit
75%
Average Return
+5.15%
reiterated a buy rating 8 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +5.15% per trade.
2 Years
xxx
Success Rate
4/4 ratings generated profit
100%
Average Return
+12.70%
reiterated a xxx
 rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1099 Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Mar 26
Strong Buy
11
10
20
17
19
Buy
0
0
0
0
0
Hold
6
14
34
31
24
Sell
1
2
2
2
1
Strong Sell
0
0
0
0
0
total
18
26
56
50
44
In the current month, 1099 has received 19 Buy Ratings, 24 Hold Ratings, and 1 Sell Ratings. 1099 average Analyst price target in the past 3 months is 23.32.
Each month's total comprises the sum of three months' worth of ratings.

1099 Financial Forecast

1099 Earnings Forecast

The previous quarter’s earnings for 1099 were HK$0.68.
The previous quarter’s earnings for 1099 were HK$0.68.

1099 Sales Forecast

The previous quarter’s earnings for 1099 were HK$316.52B.
The previous quarter’s earnings for 1099 were HK$316.52B.

1099 Stock Forecast FAQ

What is HK:1099’s average 12-month price target, according to analysts?
Based on analyst ratings, Sinopharm Group Co Ltd Class H’s 12-month average price target is 23.32.
    What is HK:1099’s upside potential, based on the analysts’ average price target?
    Sinopharm Group Co Ltd Class H has 15.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sinopharm Group Co Ltd Class H a Buy, Sell or Hold?
          Sinopharm Group Co Ltd Class H has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Sinopharm Group Co Ltd Class H’s share price target?
            The average share price target for Sinopharm Group Co Ltd Class H is 23.32. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$26.70 ,and the lowest forecast is HK$19.83. The average share price target represents 15.00% Increase from the current price of HK$20.28.
              What do analysts say about Sinopharm Group Co Ltd Class H?
              Sinopharm Group Co Ltd Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Sinopharm Group Co Ltd Class H?
                To buy shares of HK:1099, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.